Variant report
Variant | esv3501085 |
---|---|
Chromosome Location | chr3:20373148-20378146 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:20368039..20370603-chr3:20372170..20374733,2 | K562 | blood: | |
2 | chr3:20365682..20367813-chr3:20369993..20373801,3 | K562 | blood: | |
3 | chr3:20375934..20377835-chr3:20379796..20382067,2 | MCF-7 | breast: | |
4 | chr3:20369262..20370826-chr3:20371574..20373222,2 | K562 | blood: | |
5 | chr3:20370553..20372483-chr3:20373507..20376475,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs73821620 | chr3:20373153-20373154 | Active TSS Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs574135133 | chr3:20373175-20373176 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs78633931 | chr3:20373331-20373332 | Active TSS Weak transcription Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs563089246 | chr3:20373333-20373334 | Active TSS Weak transcription Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs73821621 | chr3:20373335-20373336 | Active TSS Weak transcription Bivalent Enhancer Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs12639067 | chr3:20373355-20373356 | Active TSS Weak transcription Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs564075583 | chr3:20373384-20373385 | Active TSS Weak transcription Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs73821623 | chr3:20373412-20373413 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs374367962 | chr3:20373467-20373468 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs546828137 | chr3:20373510-20373511 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs145199975 | chr3:20373518-20373519 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs550794992 | chr3:20373520-20373521 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs556468684 | chr3:20373550-20373551 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs539903814 | chr3:20373552-20373553 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs149129476 | chr3:20373554-20373555 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs557885476 | chr3:20373585-20373586 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs576351778 | chr3:20373645-20373646 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs545342469 | chr3:20373675-20373676 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs112551150 | chr3:20373681-20373682 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs375109269 | chr3:20373685-20373686 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs182686839 | chr3:20373703-20373704 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs576022252 | chr3:20373712-20373713 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs187503607 | chr3:20373733-20373734 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs370091364 | chr3:20373738-20373739 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs556322334 | chr3:20373739-20373740 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs9825734 | chr3:20373742-20373743 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs545855488 | chr3:20373751-20373752 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs190797757 | chr3:20373764-20373765 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs528050384 | chr3:20373767-20373768 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs539840616 | chr3:20373773-20373774 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs9881052 | chr3:20373780-20373781 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs552226799 | chr3:20373819-20373820 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs74798968 | chr3:20373838-20373839 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs569042810 | chr3:20373865-20373866 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs533466500 | chr3:20373985-20373986 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs376246130 | chr3:20374020-20374021 | Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs556751002 | chr3:20374021-20374022 | Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs551809536 | chr3:20374024-20374025 | Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs35782050 | chr3:20374064-20374065 | Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs566841469 | chr3:20374080-20374081 | Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs146981866 | chr3:20374127-20374128 | Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs555453762 | chr3:20374154-20374155 | Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs138058334 | chr3:20374174-20374175 | Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs188892084 | chr3:20374230-20374231 | Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs114506626 | chr3:20374280-20374281 | Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs78516234 | chr3:20374313-20374314 | Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs77463090 | chr3:20374314-20374315 | Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs78560520 | chr3:20374315-20374316 | Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs74970867 | chr3:20374316-20374317 | Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs193275492 | chr3:20374326-20374327 | Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Breast cancer | 17133270 | CNVD |
Developmental delay | 21147756 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 20164919 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:20354000-20381800 | Weak transcription | Aorta | Aorta |
2 | chr3:20372400-20374000 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
3 | chr3:20372800-20373400 | Enhancers | K562 | blood |
4 | chr3:20373000-20373400 | Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr3:20373200-20373400 | Bivalent Enhancer | A549 | lung |
6 | chr3:20373400-20374000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr3:20373400-20376600 | Weak transcription | K562 | blood |
8 | chr3:20374000-20374200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
9 | chr3:20374000-20374400 | Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
10 | chr3:20374200-20374400 | Enhancers | Cortex derived primary cultured neurospheres | brain |
11 | chr3:20374400-20374600 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
12 | chr3:20374600-20374800 | Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
13 | chr3:20374600-20374800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
14 | chr3:20374800-20375000 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
15 | chr3:20375000-20377000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
16 | chr3:20376400-20376600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
17 | chr3:20376600-20378400 | Enhancers | K562 | blood |
18 | chr3:20376600-20380200 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
19 | chr3:20377000-20377400 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
20 | chr3:20377400-20378800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
21 | chr3:20377600-20378200 | Enhancers | Stomach Mucosa | stomach |
22 | chr3:20378000-20378200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |